Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-014-2920-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis.
JAMA Neurol
December 2024
Memorial Hermann Hospital, Houston, Texas.
Article Synopsis
- Clinical trials indicate that using a mobile stroke unit (MSU) for prehospital management can lead to better outcomes for acute ischemic stroke patients who may need thrombolysis, but real-world data is limited.
- This study aimed to compare the effects of prehospital MSU management versus standard emergency services (EMS) on patient disability levels at the time of hospital discharge.
- The analysis included over 19,000 patients treated across multiple hospitals, revealing that those managed in an MSU had improved functional outcomes compared to those receiving standard EMS care.*
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
JAMA Cardiol
December 2024
Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Article Synopsis
- There’s a debate about how long patients with heart problems should take two types of medicine together, called dual antiplatelet therapy (DAPT).
- Researchers wanted to see how effective and safe different lengths of DAPT are for patients who have serious heart issues and receive a special procedure to help their hearts.
- They found that taking DAPT for just 1 month followed by another medicine might reduce serious bleeding, but didn't change the number of heart problems compared to taking DAPT for 12 months.
The evolution of the European risk stratification system for pulmonary arterial hypertension.
Eur Respir J
September 2024
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Identification of copy-number variants in patients with overgrowth disorders.
Clin Genet
November 2024
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
Overgrowth syndromes (OGS) comprise a heterogeneous group of disorders whose main characteristic is that the weight, height or the head circumference are above the 97th centile or 2-3 standard deviations above the mean for age, gender, and ethnic group. Several copy-number variants (CNVs) have been associated with the development of OGS, such as the 5q35 microdeletion or the duplication of the 15q26.1-qter, among many others.
View Article and Find Full Text PDFSGLT2 Inhibitors in Patients With Cancer Therapy-Related Cardiotoxicity: An Unexpected Benefit?
JACC Heart Fail
January 2024
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!